Geron
GERN
#6483
Rank
S$1.21 B
Marketcap
S$1.89
Share price
0.00%
Change (1 day)
8.26%
Change (1 year)

Earnings for Geron (GERN)

Earnings in 2026 (TTM): -S$45.8 Million

According to Geron's latest financial reports the company's current earnings are S$0.19 Billion. In 2025 the company made an earning of -S$65.08 Million, an increase over its 2024 earnings that were of -S$0.2 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Geron from 1996 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -S$45.8 Million-29.63%
2025 -S$65.08 Million-67.42%
2024 -S$0.2 Billion-11.23%
2023 -S$0.23 Billion30.22%
2022 -S$0.18 Billion20.15%
2021 -S$0.15 Billion50.08%
2020 -S$95.84 Million4.46%
2019 -S$91.75 Million130.68%
2018 -S$39.78 Million8.84%
2017 -S$36.55 Million-3.08%
2016 -S$37.7 Million-22080.6%
2015 S$0.17 M-100.38%
2014 -S$45.56 Million-7.14%
2013 -S$49.06 Million
2011 -S$0.12 Billion19.04%
2010 -S$97.49 Million8.45%
2009 -S$89.9 Million-2.51%
2008 -S$92.22 Million14.65%
2007 -S$80.44 Million32.68%
2006 -S$60.62 Million25.59%
2005 -S$48.27 Million4.36%
2004 -S$46.26 Million19.73%
2003 -S$38.63 Million-15.46%
2002 -S$45.7 Million1.94%
2001 -S$44.83 Million33.59%
2000 -S$33.56 Million27.53%
1999 -S$26.31 Million63.13%
1998 -S$16.13 Million15.6%
1997 -S$13.96 Million-10.66%
1996 -S$15.62 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Gilead Sciences
GILD
S$13.73 B-30,147.90%๐Ÿ‡บ๐Ÿ‡ธ USA
Incyte
INCY
S$2.27 B-5,068.38%๐Ÿ‡บ๐Ÿ‡ธ USA
CTI BioPharma
CTIC
-S$88.63 Million 93.93%๐Ÿ‡บ๐Ÿ‡ธ USA
Bio-Techne
TECH
S$0.20 B-539.25%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
-S$19.1 Million-58.22%๐Ÿ‡บ๐Ÿ‡ธ USA